HIV testing and the role of individual- and structural-level barriers and facilitators
- 1 February 2005
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 17 (2), 125-140
- https://doi.org/10.1080/09541020512331325653
Abstract
This study determined the overall prevalence of HIV testing within a community sample of heterosexual men and women at high risk for HIV infection, and analysed the gender-specific individual- and structural-level barriers and facilitators to testing. Data were collected through 1,643 personal interviews conducted in Philadelphia between 1999 and 2000. Overall, 79.4% of participants had ever taken an HIV test; women were significantly more likely to have tested than were men. Among the individual-level factors we examined, very few, including sexual and drug-using risk behaviours, were significantly associated with an increased likelihood of ever being tested for HIV. Structural-level factors were important correlates of HIV testing for both women and men. Results of this study indicate that there are gender-based similarities and differences in the correlates of testing, and that efforts to increase HIV testing must consider how structural factors, including access to health care, may deter or facilitate opportunities for HIV testing. In particular, efforts to improve the uptake of HIV testing by heterosexual men at high risk should focus on improving men's access to, and utilization of, routine health care.Keywords
This publication has 23 references indexed in Scilit:
- Moving from Apprehension to Action: HIV Counseling and Testing Preferences in Three At-Risk PopulationsAIDS Education and Prevention, 2001
- Drug users talk about HIV testing: Motivating and deterring factorsAIDS Care, 2001
- Barriers to universal prenatal HIV testing in 4 US locations in 1997American Journal of Public Health, 2001
- Gender differences in behavioural and psychosocial predictors of HIV testing and return for test results in a high-risk populationAIDS Care, 2000
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Living With HIVSexually Transmitted Diseases, 1998
- Diagnostic HIV antibody testing in the United StatesAIDS, 1996
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Characterization of Patients Accepting and Refusing Routine, Voluntary HIV Antibody Testing in Public Sexually Transmitted Disease ClinicsSexually Transmitted Diseases, 1994